These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2567285)

  • 1. The EcoRI RFLP of c-mos in patients with non-Hodgkin's lymphoma and acute lymphoblastic leukemia, compared to geriatric and non-geriatric controls.
    Chenevix-Trench G; Southall M; Kidson C
    Int J Cancer; 1989 Jun; 43(6):1034-6. PubMed ID: 2567285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic variation of the c-raf-1 proto-oncogene in human lymphoma and leukemia.
    Trench GC; Southall M; Smith P; Kidson C
    Oncogene; 1989 Apr; 4(4):507-10. PubMed ID: 2566145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence against a tumour-specific EcoRI RFLP of the c-mos locus.
    Corell B; Zoll B
    FEBS Lett; 1988 Mar; 230(1-2):81-4. PubMed ID: 2895024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.
    Crossen PE; Morrison MJ; Colls BM
    Br J Cancer; 1994 Apr; 69(4):759-61. PubMed ID: 7908219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated frequency of a SstI polymorphism of the Ets-1 oncogene in non-Hodgkin's lymphoma patients.
    Crossen PE; Morrison MJ; Colls BM
    Cancer Genet Cytogenet; 1995 Jan; 79(1):70-3. PubMed ID: 7850755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restriction fragment length polymorphisms in the ETS-1 proto-oncogene. Comparison of Saudi and Western populations.
    Parkar MH; Seid JM; Rowson JM; Stringer BM; Vencer LJ; Aur RJ; Goyns MH
    Experientia; 1988 Dec; 44(11-12):1019-20. PubMed ID: 2461869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restriction fragment length polymorphisms of L-myc and myb in human leukaemia and lymphoma in relation to age-selected controls.
    Chenevix-Trench G; Southall M; Kidson C
    Br J Cancer; 1989 Dec; 60(6):872-4. PubMed ID: 2574989
    [No Abstract]   [Full Text] [Related]  

  • 8. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.
    Dolcetti R; Pelucchi S; Maestro R; Rizzo S; Pastore A; Boiocchi M
    Eur Arch Otorhinolaryngol; 1991; 248(5):279-85. PubMed ID: 1679639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-needle aspiration of non-Hodgkin's lymphoma. Southern blot analysis for antigen receptor, bcl-2, and c-myc gene rearrangements.
    Williams ME; Frierson HF; Tabbarah S; Ennis PS
    Am J Clin Pathol; 1990 Jun; 93(6):754-9. PubMed ID: 2189291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients.
    Lidereau R; Mathieu-Mahul D; Theillet C; Renaud M; Mauchauffé M; Gest J; Larsen CJ
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7068-70. PubMed ID: 2996003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic variation of the c-raf-1 oncogene in non-Hodgkin's lymphoma.
    Chenevix-Trench G; Behm F; Westin E
    Leukemia; 1987 Jan; 1(1):82-6. PubMed ID: 2889852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults.
    Gemmati D; Ongaro A; Scapoli GL; Della Porta M; Tognazzo S; Serino ML; Di Bona E; Rodeghiero F; Gilli G; Reverberi R; Caruso A; Pasello M; Pellati A; De Mattei M
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):787-94. PubMed ID: 15159311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction fragment length polymorphism of the L-myc oncogene in non-Hodgkin's lymphoma patients from India.
    Fernandez T; Saranath D; Advani SH; Deo MG; Soman CS
    Cancer Lett; 1998 Mar; 125(1-2):165-9. PubMed ID: 9566711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between EcoRI fragment-length polymorphism of the immunoglobulin lambda variable 8 (IGLV8) gene family with rheumatoid arthritis and systemic lupus erythematosus.
    Queiroz RG; Tamia-Ferreira MC; Carvalho IF; Petean FC; Passos GA
    Braz J Med Biol Res; 2001 Apr; 34(4):525-8. PubMed ID: 11285465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single point mutation responsible for c-mos polymorphism in cancer patients.
    Lidereau R; Cole ST; Larsen CJ; Mathieu-Mahul D
    Oncogene; 1987 May; 1(2):235-7. PubMed ID: 2894001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An EcoRI restriction fragment length polymorphism (RFLP) in the human c-erb A locus.
    Mathieu-Mahul D; Xu DQ; Saule S; Lidereau R; Galibert F; Berger R; Mauchauffé M; Larsen CJ
    Hum Genet; 1985; 71(1):41-4. PubMed ID: 2993156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of an EcoRI RFLP of the c-mos locus in normal and tumor tissue of esophageal cancer patients.
    Hollstein M; Montesano R; Yamasaki H
    Nucleic Acids Res; 1986 Nov; 14(21):8695. PubMed ID: 2878411
    [No Abstract]   [Full Text] [Related]  

  • 18. Genomic EcoRI polymorphism and cosmid sequencing reveal an insertion/deletion and a new IGLV5 allele in the human immunoglobulin lambda variable locus (22q11.2/IGLV).
    Moraes Junta C; Passos GA
    Immunogenetics; 2003 Apr; 55(1):10-5. PubMed ID: 12679855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RFLP of the human c-fes proto-oncogene.
    Tesch H; Olek K; Geisel J; Van de Ven WJ; Jücker M
    Nucleic Acids Res; 1988 May; 16(9):4193. PubMed ID: 2897677
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
    Seidemann K; Zimmermann M; Book M; Meyer U; Burkhardt B; Welte K; Reiter A; Stanulla M
    J Clin Oncol; 2005 Nov; 23(33):8414-21. PubMed ID: 16293872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.